Skip to content

Jennifer McKie Adams, Director at Eton Pharmaceuticals, sold ETON on Jun 17, 2026

Data as of Oct 16

▼ SELL$1.6M50,000 shares at $32.48Jennifer McKie Adams DirectorETON Eton Pharmaceuticals, Inc.
Watch ETON
Traded
Jun 17, 2026
Disclosed
Jun 17, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jennifer McKie Adams, Director at Eton Pharmaceuticals, sold ETON on Jun 17, 2026TRADEDDISCLOSED
ETONSimilar stocks (XLV — its sector index fund), rebased to ETON's price on the disclosure day
ETON since disclosure
+53.6%
after the sale
Similar stocks (XLV) since disclosure
+17.3%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on ETON →